However, based on previous observations evidencing potentially significant differences in the antibodies specifically directed against the U94 virus antigen, even in the absence of significant differences in the anti-HHV-6A/B antibody prevalence or titer [12,45], we analyzed the antibody response against U94 in the SSc patients cohort (Figure 4B). Here, SNORD94 is linked to systemic sclerosis.